000 01405 a2200409 4500
005 20250514222443.0
264 0 _c20050511
008 200505s 0 0 eng d
022 _a1007-9327
024 7 _a10.3748/wjg.v11.i11.1663
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aYen, Cho-Li
245 0 0 _aRibavirin monotherapy increases sustained response rate in relapsers of end treatment virologic responders.
_h[electronic resource]
260 _bWorld journal of gastroenterology
_cMar 2005
300 _a1663-7 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAntiviral Agents
_xadministration & dosage
650 0 4 _aCost Savings
650 0 4 _aFemale
650 0 4 _aHepatitis C, Chronic
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aInterferon-alpha
_xadministration & dosage
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aRecurrence
650 0 4 _aRibavirin
_xadministration & dosage
650 0 4 _aTreatment Outcome
650 0 4 _aViral Load
700 1 _aChang, Jia-Jang
700 1 _aLee, Tsung-Shih
700 1 _aLiu, Ching-Jung
700 1 _aChen, Li-Wei
700 1 _aChang, Liang-Che
773 0 _tWorld journal of gastroenterology
_gvol. 11
_gno. 11
_gp. 1663-7
856 4 0 _uhttps://doi.org/10.3748/wjg.v11.i11.1663
_zAvailable from publisher's website
999 _c15457645
_d15457645